November 30, 2017
Organized: Chula Vaccine and Research Center (Chula VRC)
Sponsor: Thailand Centre of Excellent for Life Sciences (TCELS), National Vaccine Institute (Public Organization), National Science and Technology Development Agency (NSTDA), Chulalongkorn University
Venue: 12th Floor, Bhumisiri Building, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Free registration: 150 participants on the first come first serve basis
Deadline: 31 October 2017
Topics
30 November 2017
- Nucleic Acid-based Vaccine; Synthetic vector-mediated IgG generated in vivo confers protective immunity against Emerging Viral Infection
- Zika mRNA Vaccine
- Dengue DNA Vaccine
- HIV
- mRNA-based vaccine
- DNA Vaccine: from design to production
1 December 2017
- Allergy Vaccine Overview
- HDM Allergy DNA-based Vaccine
- Pre-clinical development
- In vivo expression of plasmid encoded IgG for immune check point targets by synthetic DNA: a new tool for cancer immunotherapy
Posted in Events